European Archives - Page 34 of 1199 - European Medical Journal

Study Links Bifidobacterium Deficit in Infants in the USA to Gut Dysbiosis

One in four U.S. infants lacks Bifidobacterium, a key gut microbe essential for immune and metabolic health.

Head-to-Head Trial Supports Cheaper Hepatitis C Drug

Beyond the head-to-head comparison, the study also explored innovative strategies to simplify or shorten treatment.

Illustration of scientific tools

New report calls for faster R&D for rare diseases

A report has found that while many in the UK live with rare diseases, systemic failures continue to restrict progress in treatment.

GSK’s Matt Mortimer-Ryan on behaviour-led pharma marketing

Matt Mortimer Ryan, GSK, discusses how understanding patients’ emotional drivers can unlock more impactful pharma marketing campaigns.

Unusual Yeast Fungaemia Patterns Seen in Injection Drug Users

French researchers report distinct fungal species in intravenous drug users with yeast fungaemia, suggesting the need for tailored care strategies.

PARP Inhibitor Shows Promise in Advanced Melanoma Treatment

The study highlights how HR pathway alterations, which affect roughly a fifth to a third of melanomas, may offer an opportunity for targeted treatment.

GLP-1s Reduce Heart Failure and Kidney Complications in Monoclonal Gammopathy and Type 2 Diabetes

GLP-1 receptor agonists cut heart, stroke, and kidney risks in people with MGUS and diabetes, new study finds.

Positive Feedback Boosts Performance in Urological Surgical Training

These insights are particularly relevant in minimally invasive surgery, where precision and confidence are vital.

Urban Exposures Linked to Higher Asthma Risk Across Life

A major European study finds that exposure to multiple urban environmental factors, including air pollution and lack of green space, is significantly linked to asthma risk from childhood to adulthood.

Heart MRI Study Reveals Air Pollution’s Hidden Impact on Cardiac Health

Study links air pollution to heart scarring, even in healthy individuals, raising concerns for cardiovascular risk management.